# Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

> **NCT02344992** · PHASE1 · COMPLETED · sponsor: **Adocia** · enrollment: 38 (actual)

## Conditions studied

- Diabetes Mellitus Type 1

## Interventions

- **DRUG:** BioChaperone insulin lispro
- **DRUG:** Humalog®

## Key facts

- **NCT ID:** NCT02344992
- **Lead sponsor:** Adocia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02344992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02344992, "Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02344992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*